Holm Nielsen, Signe http://orcid.org/0000-0002-4612-1014
Sardar, Samra http://orcid.org/0000-0002-5016-3671
Siebuhr, Anne Sofie http://orcid.org/0000-0003-0802-8422
Schlemmer, Annette
Schmidt, Erik Berg http://orcid.org/0000-0002-0623-5666
Bay-Jensen, Anne-Christine http://orcid.org/0000-0001-7952-9297
Karsdal, Morten A. http://orcid.org/0000-0001-5026-8740
Christensen, Jeppe Hagstrup http://orcid.org/0000-0003-1208-833X
Kristensen, Salome http://orcid.org/0000-0001-5812-5234
Funding for this research was provided by:
Den Danske Forskningsfond
Innovationsfonden
Dansk Rheumatologisk selskab
Danish Psoriasis Foundation
Article History
Received: 3 December 2020
Accepted: 7 April 2021
First Online: 22 April 2021
Declarations
:
: SHN, ASS, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. MAK and ACBJ hold stocks in Nordic Bioscience A/S.
: All participants gave their written informed consent and the regional ethics committee of North Denmark approved the study (Reference number N20120076). The study was conducted in accordance with the Declaration of Helsinki and registered at ClinicalTrials.gov (NCT01818804).